相关实验视频

Updated: Jun 4, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

在接受德克利斯塔马布治疗期间,多发性骨髓瘤引起的经常性心脏栓塞

Alexander Hurtado¹, Samuel T Luebbe¹, Emma Kilbane¹

¹McGaw Medical Center of Northwestern University, Chicago, Illinois, USA.

JACC. Case reports

|December 18, 2024

概括

双特异性疗法为多发性髓瘤患者提供了新的希望. 然而,这种双特异性疗法可能会导致新的或恶化的心周疾病,包括心脏坦波纳和心房动.

科学领域:

心脏病学心脏病学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

双特异性疗法代表了多发性骨髓瘤治疗的重大进步.
心血管不良事件是新型癌症疗法的一个关注点.

研究的目的:

报告一个可能与多发性骨髓瘤患者双特异性治疗相关的心周病例.
为了突出两种特异性药物的潜在心血管不良影响.

主要方法:

一个多发性骨髓瘤患者接受双特异性治疗的病例报告.
在治疗期间对心脏事件的临床观察.

主要成果:

患者出现了反复复发的恶性心周溢液和心脏坦波纳德.
在双特异性治疗期间观察到新发的心房动.

结论:

新出现或恶化的心周疾病可能是双特异性治疗的不良影响.
心血管监测对于服用双特异性药物的患者至关重要.

关键词:

一个心脏坦波尼德.心脏周围的输液.德克利斯塔马巴巴是什么意思

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.